Olpinat (Olanzapine)

Olanzapine, the active ingredient in Olpinat, is an atypical antipsychotic presented as a 10 mg tablet for oral use. It treats schizophrenia and bipolar I disorder in adults and adolescents. GNH USA supplies Olpinat as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olpinat as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olpinat is an atypical antipsychotic that acts on dopamine and serotonin pathways to manage serious mental health conditions.

- Schizophrenia: reduces psychotic symptoms such as delusions, hallucinations and thought disorder. - Bipolar I disorder (manic episodes): helps control mood elevation, agitation and rapid speech. - Maintenance therapy for schizophrenia or bipolar disorder: supports long‑term symptom stability and relapse prevention.

Olpinat may cause a range of adverse reactions, from mild to potentially serious.

Common Side Effects: - Weight gain - Sedation - Dry mouth - Constipation - Increased appetite - Dizziness

Serious or Rare Side Effects: - Neuroleptic malignant syndrome - Severe hyperglycaemia or new‑onset diabetes - Tardive dyskinesia - Agranulocytosis - Seizures - Elevated prolactin levels

When prescribing Olpinat, clinicians should consider several safety aspects.

- Metabolic monitoring: regular checks of weight, fasting glucose and lipid profile. - Cardiovascular assessment: monitor blood pressure and heart rate, especially in patients with pre‑existing hypertension. - CNS effects: advise patients about sedation and impaired coordination. - Pregnancy and lactation: use only if the potential benefit outweighs risk. - Elderly patients: start at lower doses and monitor for orthostatic hypotension. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Olpinate ​  

Major Interactions (Avoid): - CYP ​   -  \\  \\ \\